greeksoup/ stock research

Advanced Drainage Systems, Inc.: Q3 FY2026 earnings call

What management said about Q3 FY2026, from the documents filed with the SEC on 5 February 2026: press release. Guidance figures: 3 raised, 1 new. The quarter’s numbers.

Key takeaways

  • Sales flat, net income and EPS up: Quarter net sales rose 0.4% to $693.4 million. Net income rose 14.3% to $94.0 million, and diluted EPS rose to $1.19 from $1.04. Source
  • Adjusted EBITDA margin widened to 30.2%: Adjusted EBITDA rose 9.3% to $209.2 million in the quarter, a margin of 30.2% against 27.7% a year earlier. Source
  • Infiltrator and Allied grew above market: Management said the Infiltrator and Allied portfolios grew significantly above-market through new products, distribution and customer programs. Source
  • Domestic growth from non-residential: Management attributed the quarter's domestic sales increase primarily to the core non-residential construction end market. Source
  • Free cash flow rose to $582.4 million: Nine-month free cash flow was $582.4 million against $373.9 million. Operating cash flow was $779.1 million against $540.3 million. Source
  • NDS products complement stormwater line: Management said NDS products complement the stormwater capture portfolio and extend reach in distribution and retail channels. Source
  • Leverage about 1.5 times after closing: After closing, trailing-twelve-month leverage was approximately 1.5 times, up from 0.5 times at December 31, 2025. Source

“We are well positioned to continue executing on the value proposition, driving market conversion, and accelerating organic and inorganic growth while also generating free cash flow that enables the Company to invest in the business and return capital to shareholders.”

Scott Barbour, President and Chief Executive Officer of ADS

Guidance

AreaPeriodFigureAgainst last quarter
Net sales SourceFiscal 2026$2.990 billion to $3.040 billionRaised from $2.900 billion to $2.990 billion
Adjusted EBITDA (Non-GAAP) SourceFiscal 2026$930 million to $960 millionRaised from $900 million to $940 million
Capital expenditures SourceFiscal 2026approximately $250 millionRaised from $200 million to $225 million
Share repurchase authorization Sourcenot statednew $1 billion authorization; $1.148 billion totalNew

What changed from last quarter

  • Guidance raised: Fiscal 2026 targets were updated for net sales, Adjusted EBITDA and capital expenditures, citing year-to-date results and two months of NDS. Source
  • New: The NDS acquisition, announced as pending in the prior release, was completed in February 2026. Source
  • New: A new $1 billion stock repurchase authorization was added, bringing the total existing authorization to $1.148 billion. Source

Results and growth drivers

  • Sales flat, net income and EPS up: Quarter net sales rose 0.4% to $693.4 million. Net income rose 14.3% to $94.0 million, and diluted EPS rose to $1.19 from $1.04. Source
  • Adjusted EBITDA margin widened to 30.2%: Adjusted EBITDA rose 9.3% to $209.2 million in the quarter, a margin of 30.2% against 27.7% a year earlier. Source
  • Nine-month sales and profit higher: Nine-month net sales rose 3.7% to $2.4 billion and diluted EPS rose 5.2% to $5.02. Nine-month Adjusted EBITDA rose 8.8% to $774.9 million. Source
  • Adjusted EPS rose in the quarter: Adjusted EPS rose to $1.27 from $1.09 a year earlier. The measure excludes restructuring, transaction costs and asset disposal gains or losses. Source

Segments and regions

  • Domestic pipe sales declined: Domestic pipe sales fell $12.9 million, or 3.8%, to $326.7 million in the quarter. Source
  • Allied products sales grew 9.4%: Domestic allied products and other sales rose $14.1 million to $164.7 million in the quarter. Source
  • Infiltrator sales rose on tanks and treatment: Infiltrator sales rose $2.9 million to $152.9 million, mainly from tanks and advanced treatment products. Source
  • International sales slipped: International sales fell $1.3 million, or 2.5%, to $49.1 million in the quarter. Source

“Given the business’ strong cash generation and effective capital management strategy, we were able to complete the acquisition primarily using cash on hand.”

Scott Barbour, President and Chief Executive Officer of ADS

Products and customers

  • Infiltrator and Allied grew above market: Management said the Infiltrator and Allied portfolios grew significantly above-market through new products, distribution and customer programs. Source
  • Shift to higher-margin products: Management said it continues shifting the portfolio mix toward higher-margin products, which it said strengthens the resiliency of the business. Source
  • Profit rose across business lines: Management said profitability increased across pipe, Allied products and the Infiltrator business. Source

Costs, gross profit and margins

  • Gross profit rose 7.3%: Gross profit rose $17.6 million to $259.2 million, driven by volume growth, favorable price/cost and Allied and Infiltrator mix. Source
  • SG&A rose on NDS transaction costs: SG&A rose $8.0 million to $108.7 million, or 15.7% of sales against 14.6%, mainly from NDS transaction costs. Source
  • Restructuring for facility closures: Restructuring and realignment expense was $1.7 million in the quarter and $17.7 million year to date, covering three closures. Source

“We delivered our third consecutive strong quarter in a demand environment that is both challenging and mixed by geography.”

Scott Barbour, President and Chief Executive Officer of ADS

Demand and end markets

  • Domestic growth from non-residential: Management attributed the quarter's domestic sales increase primarily to the core non-residential construction end market. Source
  • Nine-month growth from two end markets: For the nine months, management attributed domestic sales growth to non-residential and residential construction. Source
  • Rest-of-year end markets described as mixed: Management described end markets for the rest of fiscal 2026 as facing a challenging macroeconomic environment with mixed demand. Source

Capital, cash and shareholder returns

  • Free cash flow rose to $582.4 million: Nine-month free cash flow was $582.4 million against $373.9 million. Operating cash flow was $779.1 million against $540.3 million. Source
  • Net debt fell to $437.5 million: Net debt was $437.5 million at December 31, 2025, down $524.9 million from March 31, 2025. Source
  • Liquidity of $1.6 billion: Total liquidity was $1,598.1 million, made up of $1,008.2 million cash and $589.9 million of committed facility availability. Source
  • No buybacks in nine months: The company repurchased no shares in the nine months to December 31, 2025. About $147.7 million remained available under the prior authorization. Source

NDS acquisition and leverage

  • NDS products complement stormwater line: Management said NDS products complement the stormwater capture portfolio and extend reach in distribution and retail channels. Source
  • Leverage about 1.5 times after closing: After closing, trailing-twelve-month leverage was approximately 1.5 times, up from 0.5 times at December 31, 2025. Source
  • Deal value stated in prior release: The prior release described an all-cash transaction valued at about $1.0 billion, or about $875 million adjusted for the present value of expected tax benefits.

Coming up, as management said on 5 February 2026

  • NDS results in final two months: The guidance update includes NDS results for the two months left in fiscal 2026. Source
  • Repurchases at company discretion: Buybacks under the program are made in the open market, are not obligatory, and can be suspended or ended at any time. Source

Figures management reported

FigureReported
Infiltrator organic revenue growth, nine months Source5.4%

Risks management discussed

  • Demand: Management described the demand environment as challenging and mixed by geography. Source
  • Operational: Year-to-date gross profit gains were partly offset by unfavorable fixed-cost absorption and the mix impact of Orenco. Source

Earlier plans management reported on

  • Not stated: The prior release expected the NDS closing in calendar Q1 2026. This release reports completion on February 2, 2026.
  • Not stated: The prior release cited over $25 million of expected annual cost synergies. This release does not restate that figure.

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.